Randomized intergroup trial of first line treatment for patients <=60 years with diffuse large B-cell non-Hodgkin's lymphoma (DLBCL) with a CHOP-like regimen with or without the anti-CD20 antibody rituximab -early stopping after the first interim analysis.
暂无分享,去创建一个
M. Pfreundschuh | M. Loeffler | P. Zinzani | P. Zinzani | L. Trümper | L. Shepherd | R. Pettengell | M. Trněný | D. Ma | A. Österborg | J. Waleswski | M. Loeffler | Michael Pfreundschuh | Anders Österborg | Marek Trněný | David D.F. Ma | Lorenz Trümper | L. E. Shepherd